Benzinga's Top Upgrades - Apollo Global Management (NYSE:APO)

Analysts at Morgan Stanley upgraded

Apollo Global Management LLCAPO

from Underweight to Equal-weight. The price target for Apollo Global Management is set to $23. Apollo Global Management shares closed at $21.56 yesterday. Canaccord Genuity upgraded

Sarepta Therapeutics IncSRPT

from Hold to Buy. The price target for Sarepta Therapeutics has been raised from $16.00 to $30.00. Sarepta Therapeutics' shares closed at $16.38 yesterday. Analysts at Telsey Advisory upgraded

Stage Stores IncSSI

from Market Perform to Outperform. The price target for Stage Stores is set to $21. Stage Stores' shares closed at $16.50 yesterday. Analysts at Morgan Stanley upgraded

Computer Sciences CorporationCSC

from Underweight to Equalweight. The price target for Computer Sciences has been raised from $63.00 to $73.00. Computer Sciences' shares closed at $67.66 yesterday. SunTrust Robinson Humphrey upgraded

Sarepta Therapeutics IncSRPT

from Neutral to Buy. The price target for Sarepta Therapeutics has been raised from $14.00 to $33.00. Sarepta Therapeutics' shares closed at $16.38 yesterday. Analysts at Bank of America upgraded

UBS Group AG (USA)UBS

from Neutral to Buy. UBS Group shares closed at $21.13 yesterday. Macquarie upgraded

Splunk IncSPLK

from Neutral to Outperform. Splunk shares closed at $67.94 yesterday. B Riley upgraded

Stage Stores IncSSI

from Neutral to Buy. The price target for Stage Stores has been lowered from $22.50 to $20.00. Stage Stores' shares closed at $16.50 yesterday.

Market News and Data brought to you by Benzinga APIs